Solid lipid nanoparticles (SLNs) have gained momentum over the three decades due to its role in improving bioavailability/ drug stability, controlled and targeted delivery, and as vaccine adjuvants. The excellent biocompatibility of lipid nanoparticles and ease of formulation without using toxic solvents are the main reasons for their popularity over polymeric nanoparticles. The performance of SLNs is further improved by use of modified matrix (using solid lipid + oil) e.g., second generation lipid nanoparticles i.e., nanostructured lipid carriers (NLCs). NLCs offer increased drug loading capacity, modulated release profile and stability.  The matrix (both oil and solid lipid) plays very important role in performance of NLC. Ample amount of literature is published on use of solid lipids nanoparticles; however, very limited number of publications as per our information discusses the role of oil and their effects on matrix structure.

German Innovation Award

Dr. Ranjita Shegokar, CSO was honored with a German Innovation Award 2022 jointly with Prof. Marc A. Reymond, MD MBA (AACSB), CEO, CapnoPharm GmbH, for their collaborative, innovative research work in the field of cancer.

ACES Award

German medical device firm races to provide alternative treatments to treat cancer

Revolutionizing Cancer Treatment


Hon’ble Ministers of State Shri Ashok Chandra Panda, Science & Technology, Public Enterprises, Social Security & Empowerment of Persons with Disability inaugurated the event in the auspicious presence of Padma Vibhusan Pandit Hariprasad Chaurasia and Padmashri Pt. Bhajan Sapori   15 women achievers in distinct categories felicitated with the prestigious award   Parichay Foundation presents… Continue reading AARYA Award

International Inspirational Women Awards 2020


16 Best New Drug Delivery Systems Books To Read In 2021 – BookAuthority